3.8 Article

Sodium Valproate Exacerbating an Underlying Disorder of Fatty Acid Metabolism

Journal

CASE REPORTS IN NEUROLOGY
Volume 8, Issue 3, Pages 185-192

Publisher

KARGER
DOI: 10.1159/000447087

Keywords

Sodium valproate; Mitochondrial disorder; Rhabdomyolysis

Ask authors/readers for more resources

We describe a 29-year-old female who presented with rhabdomyolysis shortly after starting a course of sodium valproate. A thorough investigation revealed a likely mitochondrial origin inducing this susceptibility. An underlying mitochondrial disorder should be considered in all patients who present with undifferentiated disease whilst taking sodium valproate. (C) 2016 The Author(s) Published by S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available